262 related articles for article (PubMed ID: 28084583)
21. Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the EMERGE multicenter retrospective chart review study.
Kotsakis A; Ardavanis A; Koumakis G; Samantas E; Psyrri A; Papadimitriou C
BMC Cancer; 2019 Jan; 19(1):88. PubMed ID: 30658600
[TBL] [Abstract][Full Text] [Related]
22. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
[TBL] [Abstract][Full Text] [Related]
23. Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
Azim HA; Abdel-Malek R; Kassem L
Clin Breast Cancer; 2018 Apr; 18(2):e187-e195. PubMed ID: 28888580
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Borm GF; Tjan-Heijnen VC
Breast Cancer Res Treat; 2013 Oct; 141(3):507-14. PubMed ID: 24104881
[TBL] [Abstract][Full Text] [Related]
25. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
[TBL] [Abstract][Full Text] [Related]
26. Metastatic breast cancer subtypes and central nervous system metastases.
Aversa C; Rossi V; Geuna E; Martinello R; Milani A; Redana S; Valabrega G; Aglietta M; Montemurro F
Breast; 2014 Oct; 23(5):623-8. PubMed ID: 24993072
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.
Grubb CS; Jani A; Wu CC; Saad S; Qureshi YH; Nanda T; Yaeh A; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lesser J; Cheng SK; Isaacson SR; Lassman AB; Connolly EP; Wang TJ
J Neurooncol; 2016 Mar; 127(1):103-10. PubMed ID: 26615564
[TBL] [Abstract][Full Text] [Related]
28. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
29. Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.
Berghoff AS; Bago-Horvath Z; Ilhan-Mutlu A; Magerle M; Dieckmann K; Marosi C; Birner P; Widhalm G; Steger GG; Zielinski CC; Bartsch R; Preusser M
Br J Cancer; 2012 Oct; 107(9):1454-8. PubMed ID: 23047551
[TBL] [Abstract][Full Text] [Related]
30. Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China.
Li Y; Li Q; Mo H; Guan X; Lin S; Wang Z; Chen Y; Zhang Y; Zhang D; Chen S; Cai R; Wang J; Luo Y; Fan Y; Yuan P; Zhang P; Li Q; Ma F; Xu B
Breast; 2021 Feb; 55():30-36. PubMed ID: 33310633
[TBL] [Abstract][Full Text] [Related]
31. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
32. Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry.
Witzel I; Laakmann E; Weide R; Neunhöffer T; Park-Simon TJ; Schmidt M; Fasching PA; Hesse T; Polasik A; Mohrmann S; Würschmidt F; Schem C; Bechtner C; Würstlein R; Fehm T; Möbus V; Burchardi N; Loibl S; Müller V
Eur J Cancer; 2018 Oct; 102():1-9. PubMed ID: 30099223
[TBL] [Abstract][Full Text] [Related]
33. [Clinical Impact of First Metastasis Sites and Subtypes in the Outcome of Brain Metastases of Breast Cancer].
Sakamoto T; Nio Y; Sakamoto M; Imai S; Uesugi K; Tamaoki M; Tamaoki M; Maruyama R
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1197-1203. PubMed ID: 32829354
[TBL] [Abstract][Full Text] [Related]
34. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
35. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.
Kim YJ; Kim JS; Kim IA
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531
[TBL] [Abstract][Full Text] [Related]
36. [Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].
Boudin L; Chabannon C; Sfumato P; Sabatier R; Bertucci F; Tarpin C; Provansal M; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Extra JM; Viens P; Gonçalves A
Bull Cancer; 2017 Apr; 104(4):332-343. PubMed ID: 28214007
[TBL] [Abstract][Full Text] [Related]
37. Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients?
Tomasevic ZI; Rakocevic Z; Tomasevic ZM; Milovanovic Z; Inic M; Kolarevic D; Lukic V; Kovac Z
J BUON; 2012; 17(2):249-53. PubMed ID: 22740201
[TBL] [Abstract][Full Text] [Related]
38. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.
Braunstein LZ; Taghian AG; Niemierko A; Salama L; Capuco A; Bellon JR; Wong JS; Punglia RS; MacDonald SM; Harris JR
Breast Cancer Res Treat; 2017 Jan; 161(1):173-179. PubMed ID: 27807809
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
Leone JP; Lee AV; Brufsky AM
Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
[TBL] [Abstract][Full Text] [Related]
40. Male breast cancer: Looking for better prognostic subgroups.
Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]